 |
 |
|
|
RESÚMENES JULIO 2007 |
Child & Adolescent Disorders
(Haga un click en la información del journal para acceder al resúmen)
Literature Review: Update on Amphetamine Neurotoxicity
and Its Relevance to the Treatment of ADHD
Claire Advokat
Journal of Attention Disorders, Vol. 11, No.
1, 8-16 (2007)
Effect of Regulatory Warnings on Antidepressant Prescribing for Children
and Adolescents
Benji T. Kurian, Wayne A. Ray, Patrick G. Arbogast,
D. Catherine Fuchs, Judith A. Dudley, William O. Cooper
Arch Pediatr Adolesc
Med. 2007;161:690-696
Maternal Depressive Symptoms, Father's Involvement, and the Trajectories of
Child Problem Behaviors in a
Jen Jen Chang, Carolyn T. Halpern,
Jay S. Kaufman
Arch Pediatr Adolesc
Med. 2007;161:697-703
Intergenerational Transmission of Childhood Conduct
Problems. A Children of Twins Study
Brian M. D’Onofrio, Wendy S. Slutske,
Eric Turkheimer, Robert E. Emery, K. Paige Harden,
Andrew C. Heath, Pamela A. F. Madden, Nicholas G. Martin
Arch
Gen Psychiatry. 2007;64:820-829
Effects of low
birth weight, maternal smoking in pregnancy and social class on the phenotypic
manifestation of Attention Deficit Hyperactivity Disorder and associated
antisocial behaviour: investigation in a clinical
sample
Kate Langley, Peter A Holmans, Marianne BM van den Bree
and Anita Thapar
BMC
Psychiatry
2007, 7:26
TEXTO GRATUITO
Safety and usage of atypical antipsychotic
medicines in children : a nationwide prospective
cohort study
Harrison-Woolrych M, Garcia-Quiroga J, Ashton
J, Herbison P
Children and
Adolescents with Autism Exhibit Reduced MEG Steady-State Gamma Responses
Tony W. Wilson,
Donald C. Rojas, Martin L. Reite, Peter D. Teale and Sally J. Rogers
Biological
Psychiatry. Volume 62, Issue 3, 1 August 2007, Pages 192-197
Inhibitory Control
in High-Functioning Autism: Decreased Activation and Underconnectivity
in Inhibition Networks
Rajesh K. Kana,
Timothy A. Keller, Nancy J. Minshew and Marcel Adam
Just
Biological
Psychiatry. Volume 62, Issue 3, 1 August 2007, Pages 198-206
An Event Related
Functional Magnetic Resonance Imaging Study of Facial Emotion Processing in Asperger Syndrome
Quinton Deeley, Eileen M. Daly, Simon Surguladze,
Lisa Page, Fiona Toal, Dene
Robertson, Sarah Curran, Vincent Giampietro, Marc
Seal, Michael J. Brammer, Christopher Andrew, Kieran
Murphy, Mary L. Phillips and Declan G.M. Murphy
Biological
Psychiatry. Volume 62, Issue 3, 1 August 2007, Pages 207-217
Risperidone
Exerts Potent Anti-aggressive Effects in a Developmentally Immature Animal
Model of Escalated Aggression
Lesley
A. Ricci, Daniel F. Connor, Randall Morrison and Richard H. Melloni
Jr.
Biological
Psychiatry. Volume 62, Issue 3, 1 August 2007, Pages 218-225
Risperidone
and Cognitive Function in Children With Disruptive
Behavior Disorders
Gahan J. Pandina, Robert Bilder, Philip D.
Harvey, Richard S.E. Keefe, Michael G. Aman and
Georges Gharabawi
Biological
Psychiatry. Volume 62, Issue 3, 1 August 2007, Pages 226-234
Caudate Nucleus Is
Enlarged in High-Functioning Medication-Naive Subjects with Autism
Marieke Langen, Sarah Durston, Wouter G. Staal, Saskia
J.M.C. Palmen and Herman van Engeland
Biological
Psychiatry. Volume 62, Issue 3, 1 August 2007, Pages 262-266
Psychopathology in
children of bipolar parents
Manpreet K.
Singh, Melissa P. DelBello, Kevin E. Stanford, Cesar Soutullo, Patricia McDonough-Ryan, Susan L. McElroy and
Stephen M. Strakowski
Journal of Affective
Disorders. Volume 102, Issues 1-3, September 2007, Pages 131-136
Differentiating major depressive disorder in
youths with attention deficit hyperactivity disorder
R. Diler, W. Daviss, A. Lopez, D. Axelson, S. Iyengar, B. Birmaher
Journal
of Affective Disorders, Volume 102, Issue 1-3, Pages 125-130
Long-term, open-label venlafaxine
extended-release treatment in children and adolescents with major depressive
disorder
Emslie GJ, Yeung PP, Kunz NR
CNS Spectr. 2007 Mar;12(3):223-33
Body Mass Indexes
and Lipid Profiles in Hospitalized Children and Adolescents Exposed to Atypical
Antipsychotics
Nick C. Patel,
Monica Hariparsad, Mary Matias-Akthar,
Michael T. Sorter, Drew H. Barzman, John A. Morrison,
Kevin E. Stanford, Stephen M. Strakowski, Melissa P. DelBello
Journal of
Child and Adolescent Psychopharmacology. 2007, 17(3): 303-311
Observed Clinical
and Health Services Outcomes in Pediatric Inpatients Treated with Atypical Antipsychotics: 1999–2003
Scott C.
Flanders, Robert L. Findling, Eric A. Youngstrom, Gahan J. Pandina, Marcia F.T. Rupnow,
Sarah E. Jensik, Gabrielle A. Carlson
Journal of Child and Adolescent Psychopharmacology. 2007, 17(3): 312-327
Indication and
Use of Drug Products Used to Treat Attention-Deficit/Hyperactivity Disorder: A
Cross-Sectional Study with Inference on the Likelihood of Treatment in
Adulthood
Allen Brinker,
Andrew Mosholder, Stephanie D. Schech,
Margaret Burgess, Mark Avigan
Journal of Child and Adolescent Psychopharmacology. 2007, 17(3): 328-333
Quetiapine
Addition in Methylphenidate Treatment-Resistant Adolescents with Comorbid ADHD, Conduct/Oppositional-Defiant Disorder, and
Aggression: A Prospective, Open-Label Study
William G. Kronenberger, Ann L. Giauque, Deborah E. Lafata, Bradley N. Bohnstedt,
Laura E. Maxey, David W. Dunn
Journal of Child and Adolescent Psychopharmacology. 2007, 17(3): 334-347
Medication Use Among Children with Autism Spectrum Disorders
Donald P. Oswald,
Neil A. Sonenklar
Journal of Child and Adolescent Psychopharmacology. 2007, 17(3): 348-355
Electrophysiological
Effects of Stimulant Treatment on Inhibitory Control in Children with
Attention-Deficit/Hyperactivity Disorder
Steven R. Pliszka, Mario Liotti, Brigitte
Y. Bailey, Ricardo Perez III, David Glahn, Margaret Semrud-Clikeman
Journal of Child and Adolescent Psychopharmacology. 2007, 17(3): 356-366
Is Age-at-Onset
Criterion Relevant for the Response to Methylphenidate in Attention-Deficit/Hyperactivity
Disorder?
Marcelo C. Reinhardt, Lucia Benetti; Marcelo
M. Victor,
Eugenio H. Grevet, Paulo Belmonte-de-Abreu, Stephen V. Faraone, and Luis A. Rohde
J Clin Psychiatry 2007;68:1109–1116
A Randomized,
Placebo-Controlled Clinical Trial of Bupropion for
the Prevention of Smoking in Children and Adolescents With
Attention-Deficit/Hyperactivity Disorder
Michael C. Monuteaux,
Thomas J. Spencer, Stephen V. Faraone, Angela M.
Wilson, and Joseph Biederman
J Clin Psychiatry 2007;68:1094-1101
Selective
serotonin reuptake inhibitors (SSRIs) and routine
specialist care with and without cognitive behaviour therapy in adolescents
with major depression: randomised controlled trial
Ian Goodyer, Bernadka Dubicka, Paul Wilkinson, Raphael Kelvin, Chris Roberts, Sarah Byford, Siobhan Breen, Claire Ford,
Barbara Barrett, Alison Leech, Justine Rothwell, Lydia White, Richard Harrington
TEXTO GRATUITO
Risk Factors for
Development of Subclinical Hypothyroidism during Valproic Acid Therapy
M.A. Mikati, H. Tarabay, A. Khalil, A.C. Rahi, D. El Banna and S. Najjar
The
Journal of Pediatrics. Volume 151, Issue 2, August 2007, Pages 178-181
Combined fluoxetine plus cognitive behavioural
therapy is more effective than monotherapy or placebo
for adolescents with depression
Evidence-Based
Mental Health
2007;10:84
Cognitive behavioural therapy plus fluoxetine
offers some safety advantages over fluoxetine alone
in adolescents with depression
Emslie G, Kratochvil C,
Vitiello B, et al.
Evidence-Based
Mental Health
2007;10:85
Review:
Antidepressants may increase risk of self-harm or suicidal behaviour
in children and adolescents
Dubicka B, Hadley S, Roberts C.
Evidence-Based Mental Health
2007;10:89
Psychotropic drug
prescribing in child and adolescent learning disability psychiatry
David Bramble
Journal of Psychopharmacology, Vol. 21, No. 5, 486-491
(2007)